# Role of Enteral Lactoferrin as an Adjuvant for Prevention of Sepsis Among Preterm Neonates

> **NCT07480434** · PHASE1 · COMPLETED · sponsor: **Zartash Sial Paeds Med** · enrollment: 180 (actual)

## Conditions studied

- Sepsis

## Interventions

- **BIOLOGICAL:** Bovine Lactoferrin Supplement

## Key facts

- **NCT ID:** NCT07480434
- **Lead sponsor:** Zartash Sial Paeds Med
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-10-01
- **Primary completion:** 2025-03-31
- **Final completion:** 2025-03-31
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2026-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07480434

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07480434, "Role of Enteral Lactoferrin as an Adjuvant for Prevention of Sepsis Among Preterm Neonates". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07480434. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*